Clinical Observation Of Xifeng Huoluo Capsule On Parkinson's Disease With Wind-yang Internal Movement Syndrome And Blood Stasis Syndrome

Objective:To study and analyze the clinical observation effect of Xifenghuoluo capsule on patients with Parkinson's disease(PD).Methods:60 patients with PD in our hospital from September 2016 to May 2018 were selected as the objects of this study.The patients were randomly divided into control group and treated group,30 cases individually.The control group was treated with Medopar(MDB),while the treated group was treated with MDB plus Xifenghuoluo capsule.Results:1.After statistical analysis,there was no significant difference in gender,age,disease course,and H&Y classification between the twogroups(p>0.05).2.Compared with control group,it is shown that lower UPDRS scale score,Traditional Chinese Medicine(TCM)score and Parkinson's Disease Questionnaire(PDQ-39)in treated group with a statistically significant difference(P<0.05).Additionally,the dose of MDB was significantly reduced in treated group for long-term treatment than control group(P<0.05).Conclusions:It suggested that there is more effective and better outcome in PD patients with Xifenghuoluo capsule than MDB,so it will supply a new additional way to treat PD.